Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07863635 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Moderna
49 trials monitored
See 3 trials at risk
The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1283 and mRNA-1273 (variant formulations) within the current epidemiological environment
Trial Details
NCT Number NCT07863635
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 SARS-CoV-2
Related terms Coronavirus Infections, COVID-19
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov